Leerink Partners Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform

Go back to Leerink Partners Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 228.61 +4.01 (1.79%)
Previous Close $224.60    52 Week High $109.10 
Open $226.27    52 Week Low $31.38 
Day High $230.91    P/E N/A 
Day Low $222.01    EPS $-1.45 
Volume 1,603,693